drugset / Trial / NCT00003522
Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
NaSingle-groupOpen-labelTreatment
Summary
Current therapies for Cancer of the Small Intestine provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Cancer of the Small Intestine. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Cancer of the Small Intestine.
Timeline
- Start
- 1997-08-13
- Primary completion
- 1997-12-14
- Completion
- 1997-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Astugenal | Unknown | — | Intravenous |
| Subject | antineoplaston A10 | Small molecule | — | Intravenous |